Surveillance for cholangiocarcinoma in patients with primary sclerosing cholangitis: Can we be more proactive?

Affiliations

¹ Liver Unit, Sheffield Teaching Hospitals Sheffield UK, Sheffield, UK.
² PSC Support, Oxford, UK.
³ National Institute for Health Research Birmingham Biomedical Research Centre, Centre for Liver and Gastroenterology Research, University of Birmingham, Birmingham, United Kingdom, Birmingham, UK.
⁴ Institute of Liver Studies, King's College Hospital NHS Foundation Trust, London, UK.
⁵ Department of Clinical Radiology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.

Editorial

Dermot Gleeson et al. Frontline Gastroenterol. 2022.

. 2022 Aug 4;14(2):162-166.

doi: 10.1136/flgastro-2022-102172. eCollection 2023.

¹ Liver Unit, Sheffield Teaching Hospitals Sheffield UK, Sheffield, UK.
² PSC Support, Oxford, UK.
³ National Institute for Health Research Birmingham Biomedical Research Centre, Centre for Liver and Gastroenterology Research, University of Birmingham, Birmingham, United Kingdom, Birmingham, UK.
⁴ Institute of Liver Studies, King's College Hospital NHS Foundation Trust, London, UK.
⁵ Department of Clinical Radiology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.

No abstract available

Keywords: CHOLANGIOCARCINOMA; PRIMARY SCLEROSING CHOLANGITIS.

Conflict of interest statement

Competing interests: None declared.

1. Aune D, Sen A, Norat T, et al. . Primary sclerosing cholangitis and the risk of cancer, cardiovascular disease, and all-cause mortality: a systematic review and meta-analysis of cohort studies. Sci Rep 2021;11:10646. 10.1038/s41598-021-90175-w - DOI - PMC - PubMed
1. Ranieri V, Kennedy E, Walmsley M, et al. . The primary sclerosing cholangitis (PSC) wellbeing study: understanding psychological distress in those living with PSC and those who support them. PLoS One 2020;15:e0234624. 10.1371/journal.pone.0234624 - DOI - PMC - PubMed
1. Walmsley M, Leburgue A, Thorburn D, et al. . FRI-062-Identifying research priorities in primary sclerosing cholangitis: Driving clinically meaningful change from the patients’ perspective. J Hepatol 2019;70:e412–3. 10.1016/S0618-8278(19)30812-6 - DOI
1. Walmsley M. Clinical need in PSC and clinically meaningful change: what is important to patients? 2016. Available: www.pscsupport.org.uk/unmetneeds
1. Bergquist A, Ekbom A, Olsson R, et al. . Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol 2002;36:321–7. 10.1016/S0168-8278(01)00288-4 - DOI - PubMed